Welcome to the Oncomine Blog

Shifting the Paradigm: Broader Patient Access to Personalized Oncology Treatments Hinges on In-House Comprehensive Genomic Testing

11/06/2019

We are living in an unprecedented time in the collective fight against cancer, where recent developments in drug development are giving rise to a new era of hope.  In 2018, the U.S. Food and Drug Administration (FDA) approved 59 novel therapies,..

The OncomineWorld Experience from Behind the ...

BACKGROUND:  There is little to no point in saying that we are all living in an unprecedented time, ...

Comprehensive Biomarker Testing Reveals RET ...

It’s been a tough road for Melissa Crouse, sometimes almost deadly. She had a lobe of her left lung ...

Building a Case for In-House Next Generation ...

Diagnostics lab team demonstrates how insourcing NGS makes sound financial sense and helps deliver ...

Q2 Solutions Eyes Genexus System as its ...

When it comes to supporting clinical trials, having a global footprint is simply not enough for ...

The Importance of Detecting the Most Fusions ...

In recent years, we’ve seen an increasing number of new therapies emerge that target gene fusions ...


Stay Up-To-Date

Connect project to a Slack channel and everyone in the team will be notified

Subscribe